Wells Fargo
VMD icon

Wells Fargo’s Viemed Healthcare VMD Stock Holding History

Wells Fargo’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
31,168
+18,999
+156% +$188K ﹤0.01% 4847
2026
Q1 		$112K Sell
12,169
-25,234
-67% -$210K ﹤0.01% 5047
2025
Q4 		$278K Buy
37,403
+15,999
+75% +$110K ﹤0.01% 4878
2025
Q3 		$145K Buy
21,404
+3,395
+19% +$23K ﹤0.01% 5112
2025
Q2 		$124K Buy
18,009
+1,623
+10% +$11K ﹤0.01% 5069
2025
Q1 		$119K Buy
16,386
+362
+2% +$2.84K ﹤0.01% 5008
2024
Q4 		$129K Buy
16,024
+5,461
+52% +$47.4K ﹤0.01% 5057
2024
Q3 		$77.4K Sell
10,563
-417
-4% -$2.98K ﹤0.01% 5161
2024
Q2 		$71.9K Buy
10,980
+772
+8% +$5.82K ﹤0.01% 5129
2024
Q1 		$96.3K Buy
10,208
+1,626
+19% +$13.9K ﹤0.01% 4918
2023
Q4 		$67.4K Buy
8,582
+1,000
+13% +$7.26K ﹤0.01% 5146
2023
Q3 		$51K Sell
7,582
-6,418
-46% -$52.6K ﹤0.01% 5166
2023
Q2 		$137K Buy
14,000
+12,960
+1,246% +$132K ﹤0.01% 4826
2023
Q1 		$10K Hold
1,040
– – ﹤0.01% 5860
2022
Q4 		$7.89K Buy
+1,040
New +$7.04K ﹤0.01% 5638
2022
Q2 		– Sell
-45,041
Closed -$224K – 7573
2022
Q1 		$224K Sell
45,041
-19,298
-30% -$89.6K ﹤0.01% 4916
2021
Q4 		$336K Sell
64,339
-197,418
-75% -$1.1M ﹤0.01% 4972
2021
Q3 		$1.45M Buy
261,757
+74,257
+40% +$483K ﹤0.01% 3928
2021
Q2 		$1.34M Sell
187,500
-141,758
-43% -$1.23M ﹤0.01% 4009
2021
Q1 		$3.33M Buy
329,258
+110,549
+51% +$1.04M ﹤0.01% 3239
2020
Q4 		$1.7M Buy
218,709
+10,343
+5% +$91K ﹤0.01% 3616
2020
Q3 		$1.8M Buy
208,366
+189,444
+1,001% +$1.91M ﹤0.01% 3400
2020
Q2 		$181K Buy
+18,922
New +$147K ﹤0.01% 4959
2020
Q1 		– Sell
-10,000
Closed -$62K – 6863
2019
Q4 		$62K Buy
+10,000
New +$69.3K ﹤0.01% 5445

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Wells Fargo's VMD Position: Q2 2026 in Review

Wells Fargo increased its Viemed Healthcare (VMD) stake by 156% in Q2 2026, buying an estimated $188K and bringing the position to 31,168 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #4847.

Wells Fargo first reported a position in VMD in Q4 2019 and has held it in 24 quarters since. The position peaked at $3.33M in Q1 2021. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Wells Fargo held 31,168 shares of Viemed Healthcare worth $355K as of Q2 2026.
  • Wells Fargo bought 18,999 Viemed Healthcare shares in Q2 2026, an estimated $188K.
  • Viemed Healthcare made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4847 holding.
  • Wells Fargo first reported a position in Viemed Healthcare in Q4 2019 and has held it in 24 quarters since.
  • Wells Fargo's Viemed Healthcare position peaked at $3.33M in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.